Advances in antiarthritic therapeutics

This publication has 65 references indexed in Scilit:

• Late Complications of Immune Deviation Therapy in a Nonhuman Primate
  Science, 1996
• Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
  Journal of the American Academy of Dermatology, 1996
• Leflunomide
  Clinical Immunotherapeutics, 1996
• Disease‐modifying activity of SK&F 106615 in rat adjuvant‐induced arthritis. Multiparameter analysis of disease including magnetic resonance imaging and bone mineral density measurements
  Arthritis & Rheumatism, 1996
• Minocycline in Rheumatoid Arthritis
  Clinical Immunotherapeutics, 1996
• Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits
  Inflammation Research, 1995
• Tenidap: A Novel Cytokine-modulating Antirheumatic Drug for the Treatment of Rheumatoid Arthritis
  Scandinavian Journal of Rheumatology, 1994
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.
  The Journal of Experimental Medicine, 1993
• The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells
  International Journal of Immunopharmacology, 1993
• A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
  Nature, 1992